Suchergebnisse - "Yamada, Suguru"

PubPharm (11)

1

Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)

enthalten in: Annals of surgery | 2022

von Yamaguchi, J. | Yokoyama, Y. | Fujii, T. | +10

2

Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Nakayama, G. | Takano, N. | Taniguchi, H. | +27

3

An Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus

enthalten in: The oncologist | 2020

von Kanda, M. | Koike, M. | Iwata, N. | +8

4

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)

enthalten in: International journal of clinical oncology | 2020

von Hattori, N. | Nakayama, G. | Uehara, K. | +12

5

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial) : study protocol for a single arm phase II study

enthalten in: Nagoya journal of medical science | 2019

von Takano, N. | Yamada, S. | Hirakawa, A. | +20

6

Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)

enthalten in: The oncologist | 2018

von Nakayama, G. | Mitsuma, A. | Sunagawa, Y. | +21

7

Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease : a single-center, single-arm phase II trial (CCOG-1107 study)

enthalten in: Surgery today | 2018

von Asada, T. | Nakayama, G. | Tanaka, C. | +7

8

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer : a multi-center, single-arm, phase II study (CCOG-0902)

enthalten in: BMC cancer | 2017

von Nakayama, G. | Ishigure, K. | Yokoyama, H. | +18

9

Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis

enthalten in: Annals of surgery | 2017

von Satoi, S. | Fujii, T. | Yanagimoto, H. | +12

10

Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer : A Prospective Multicenter Phase II Trial (NAC-GA Trial)

enthalten in: Oncology | 2017

von Okada, K. | Shimokawa, T. | Hirono, S. | +10